Optimvia is a biopharmaceutical company specializing in developing therapeutic assets that meet critical unmet medical needs.
Subscribe to our news
We will keep you up to date with the latest developments
Edmundo Muniz’s twenty-five-year scientific and business management career has spanned international, federal and local public health government organizations, large pharmaceutical and small biotechnology companies.
For a decade, he held senior executive roles at Eli Lilly and Company including Cardiovascular Business Unit Leader, and Vice President of Global Oncology Clinical Development. Most recently, from 2014-2019, he served as CEO of Certara, the global leader in drug development modeling and simulation.
Optimvia is a biopharmaceutical company specializing in developing therapeutic assets that meet critical unmet medical needs.